It is interesting to note that CDK6 is known to regulate both cell cycle progression and differentiation (reviewed in [29]), suggesting that mir-124- and miR-137-mediated inhibition of CDK6 may, in part, account for the observed effects on GBM cell proliferation and differentiation in this study. The gene discussed is CDK6; the disease is glioblastoma.